Appendix

Appendix: Key Information on Newly Approved AML Drugs

Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C

This article is a part of a JADPRO certified supplement, Optimizing Treatment and Improving Outcomes for Patients With Acute Myeloid Leukemia: A Guide for Advanced Practitioners Table of Contents Acute Myeloid Leukemia: An Ever-Ch...

Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management

This article is a part of a JADPRO certified supplement, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events Table of Contents Immuno-Oncology Essentials: An Overview Meeting the Challenge of I...

Appendix

Compiled by Lisa A. Kottschade, APRN, MSN, CNP

Appendix

Appendix. Treatment Regimens for Chronic Lymphocytic Leukemia

Appendix

Appendix

Multiple Myeloma Treatment Options for Newly Diagnosed, Relapsed, and Refractory Disease